Private Equity’s AI Mirage: Recurring Revenue Myths and the Great Unwind in Alternative Assets

The private markets were supposed to be the sanctuary from public market volatility, a place where ‘recurring revenue’ was gospel and AI was the new messiah. Instead, the sector is waking up to a hangover that even the most creative IR decks can’t paper over. Investors, once happy to pay up for predictable SaaS cash flows and AI-fueled growth projections, are now asking uncomfortable questions. The latest wave of skepticism, as reported by the Wall Street Journal, is less a correction and more an existential reckoning for the private equity complex.

Let’s be honest: the entire ‘recurring revenue’ pitch was always a little too tidy. Now, with AI-driven business models underperforming and lending standards tightening, the cracks are impossible to ignore. Private credit, once the hottest ticket in town, is suddenly facing mark-to-market reality as loan portfolios get repriced. The irony is delicious: the very funds that sold themselves as immune to public market swings are now being forced to mark down assets as the AI trade unravels across both public and private spheres.

The facts are stark. According to the WSJ (2026-02-06), investors are pulling back from private equity and private credit deals that rely on ‘predictable’ AI-driven revenues. Valuations are being slashed, and the secondary market is awash with discounted stakes. The AI selloff in public markets has bled into private portfolios, with tech-focused funds seeing markdowns of 15-30% on recent vintages. Lenders are tightening covenants, and some deals are being restructured before the ink is dry. The days of ‘growth at any price’ are over. Now, it’s all about cash flow and real, not synthetic, demand.

This is a sea change. For years, private equity rode the AI hype train, bidding up SaaS and fintech assets on the back of ‘sticky’ revenues and endless TAM expansion. The playbook was simple: buy, lever, and sell to the next fund or IPO window. Now, with IPO markets shut and public comps in freefall, the exit doors are closing. The knock-on effect is brutal. LPs are balking at new commitments, GPs are scrambling to shore up portfolios, and the shadow banking system is under stress as private credit marks get dragged lower by the public market rout.

The context is global. Asian markets are reeling from the AI selloff, with South Korea’s memory stocks plunging and Indonesia’s Moody’s downgrade adding to the gloom. In the US, the tech-led correction has erased trillions in paper gains, and even the most ‘defensive’ private assets are being re-rated. The macro backdrop is hostile: the Fed is holding rates at 3.50%, 3.75%, and the cost of capital is choking off new deals. The old model, buy growth, lever up, exit at a premium, is broken. The new model? Survive, delever, and pray for a reopening of the IPO window.

The analysis is damning. The ‘recurring revenue’ myth was always predicated on low rates, easy money, and a belief in AI’s transformative power. Now, with rates higher for longer and AI capex eating into margins, the cracks are showing. Private equity funds are being forced to mark down assets, and the secondary market is flooded with discounted stakes. Private credit, once seen as a safe haven, is facing its own reckoning as loan losses mount and covenants are breached. The entire alternative asset complex is being repriced, and the pain is far from over.

Strykr Watch

For allocators and traders, the signals are clear. Secondary market discounts on private equity stakes are widening, with some tech-focused funds trading at 30% below NAV. Private credit spreads are blowing out, and default rates are ticking higher. Watch for further markdowns in Q1 reports, and pay close attention to funds with heavy AI and SaaS exposure. The real tell will be in fundraising: if LPs continue to pull back, expect a wave of forced asset sales and more aggressive markdowns. On the public side, keep an eye on listed private equity vehicles and BDCs, they’re the canaries in the coal mine.

The risks are legion. The biggest is a liquidity crunch. If LPs refuse to re-up and secondary buyers demand even steeper discounts, GPs will be forced to sell assets at fire-sale prices. Second, a wave of defaults in private credit could trigger a broader re-rating of risk across the alternative asset space. Third, regulatory scrutiny is rising, with the SEC and global counterparts looking hard at valuation practices and disclosure. The risk is not just mark-to-market pain, but a structural shift in how private assets are valued and traded.

Opportunities? For the brave, distressed secondary stakes in high-quality funds could offer outsized returns, if you can stomach the illiquidity and potential for further markdowns. On the credit side, senior secured loans with strong covenants are the only game in town. For public market traders, shorting listed private equity vehicles or BDCs with heavy tech exposure is a high-conviction play. The real opportunity is in patience: wait for the forced sellers, then pick up assets at true distressed prices.

Strykr Take

The private equity AI mirage is evaporating, and the great unwind is only just beginning. The days of easy money and ‘recurring revenue’ fairy tales are over. For traders and allocators, the playbook is clear: get defensive, get liquid, and wait for the real bargains to emerge. The pain isn’t over, but the opportunities are coming.

datePublished: 2026-02-06 10:46 UTC